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Introduction
Sudden cardiac death (SCD) in the United States is linked to 
more than 450,000 deaths annually1 and contributes to more 
than 30% (17.1 million) of all cardiovascular mortality world-
wide.2 Malignant dysrhythmias such as ventricular tachycar-
dia evolving into ventricular fibrillation cause two-thirds of 
SCDs.3 An implantable cardioverter defibrillator (ICD) is the 
recommended intervention for this high-risk patient population 
due to its advantage over pharmacologic treatment, resulting 
in a significant surge of ICDs implanted.4 Therapy has focused 
on the identification of high-risk individuals for SCD includ-
ing those with low ejection fraction or history of malignant 
dysrhythmias.5 The ICD is designed to detect and treat these 
malignant ventricular dysrhythmias through antitachycardia 
pacing or shock therapy restoring a sinus rhythm.6 Survival 
rates have improved over the past 20 years with ICD therapy,7 
noting a 30%–50% decrease in mortality.6,8
The Diagnostic and Statistical Manual of Mental Disorders, 
Fifth Edition (DSM-V), states that posttraumatic stress 
disorder (PTSD) is a condition that occurs in people who 
are unprotected against extreme stress or a traumatic life- 
threatening event, resulting in fear, helplessness, or horror.9 
A single ICD shock or an ICD storm (multiple consecutive 
ICD shocks) may lead to PTSD.10 Patients who develop PTSD 
attempt to avoid reminders and have frequent thoughts of the 
event.11 They have consistent adverse views and expectations 
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AbstrAct
IntroductIon: Implantable cardioverter defibrillator (ICD) recipients who suffer from posttraumatic stress disorder (PTSD) are known to be 
associated with significant cardiac-specific mortality. Clinical observations suggest that PTSD is frequently undetected in ICD recipients followed up at 
electrophysiology (EP) outpatient clinics. Early recognition of PTSD is important to reduce the risk of serious manifestations on patient outcomes.
Methods: All ICD recipients aged 19 years or older at the Washington University School of Medicine (WASHU) EP clinic, a large urban EP clinic, 
were invited to participate in the project. An informed consent letter with an attached primary care: posttraumatic stress disorder (PC: PTSD) survey was 
offered to the participants who met the inclusion criteria. Those who completed the survey were included in the project. Individuals with positive survey 
result were offered a referral to mental health services. Comparisons between PTSD and non-PTSD patients were done using a two-sample t-test for 
continuous variables. Using Fisher’s exact test, PTSD prevalence was compared to the study by Ladwig et al in which prevalence was determined as the 
proportion of patients with positive findings of PTSD (n = 38/147). All analyses were conducted using SAS v9.4. The proportion of patients having PTSD 
was determined and an exact 95% confidence interval was evaluated based on the binomial distribution.
results: Using a convenience sample, 50 ICD recipients (33 males and 17 females) were enrolled. The project had a 30-day outcome period. Nine (18%) 
of the 50 participants had positive PC: PTSD findings and all these nine participants were referred to a mental health specialist. The current project demon-
strated an 18% (9/50) PTSD prevalence rate when compared to a 26% (38/147) prevalence rate in the study by Ladwig et al (P = 0.34). Although this project 
did not demonstrate 20% PTSD prevalence rate, as hypothesized, the 18% PTSD prevalence rate is consistent with previous research.
conclusIon: The prevalence of PTSD noted in the current project is consistent with previous research and validates underrecognition of PTSD in 
ICD patients. Offering a referral to all ICD recipients at EP clinic visits with a positive PC: PTSD screening to a mental health specialist is an important 
step in reducing the risk of serious manifestations on patient outcomes.
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about themselves or their environment and demonstrate a 
hyperarousal syndrome.11 Symptoms that persist for more 
than 30 days causing impairment in day-to-day functioning 
have been classified as PTSD.11
The DSM-V11 reported the US lifetime PTSD prevalence 
rate of 8.7%.12 The mechanism underlying the development of 
PTSD in ICD patients is not well documented.9 It is not clear 
if life-threatening dysrhythmias provoke PTSD or whether 
ICD shocks trigger and maintain PTSD.9
With improved SCD survival rates, a higher postrecovery 
PTSD potential exists for ICD patients noting life-threatening 
events.13,14 As a result, there is a relationship between adverse 
cardiac events and subsequent traumatic symptoms.15 Post-
survival patients are susceptible to reexperience the cardiac 
incident or ICD shocks. PTSD sufferers commonly encoun-
ter flashbacks of medical interventions and dreams of cardiac 
arrest and surgical procedures. In addition, episode remin ders 
result in avoidance of situations causing tachycardia such as 
sexual activity, exercise, and arousal symptoms triggering 
obsessions with heart rate, chest pain, or insomnia.12
Many studies have suggested that an ICD increases the 
quality of life (QoL) for most recipients.16 Although ICDs 
improve survival rates,7 the severity of disease, comorbidities, 
underlying cardiac disease, life-threatening dysrhythmia, fre-
quent ICD shocks or electrical storms, poor social support, 
younger age at implantation, gender, and/or a poor under-
standing of the therapy may increase anxiety, depression, and 
posttraumatic stress symptoms.6,9,17 The incidence of PTSD in 
ICD recipients is approximately 20% with Type D personality, 
with comorbidities, and frequent shock therapy.9 According 
to Shiga et al9, ICD patients with Type D personality, known 
as a highly reactive stress disorder, may have an increased risk 
for developing anxiety. Ventricular dysrhythmias result in the 
provocation of anxiety among ICD recipients.9,18 In addition, 
depression has been observed in approximately 30% of ICD 
recipients, and shock therapy may contribute to the persis-
tence of depression.9
While the recipient may perceive the ICD shock (par-
ticularly ICD storm) as traumatic, it is important to note that 
the ICD population seems to differ from other PTSD popu-
lations in the development of PTSD symptoms. In non-ICD 
recipients, the subsequent trauma experience is not likely. The 
ICD recipient lives with the realistic and tactile threat every 
second of every day.10
nursing Focus
Nursing is concerned with the diagnosis and monitoring of 
patients’ responses to health problems, with health advance-
ment and optimization, and with the prevention of disease.19 
Nurses serve a focal role in the development of interventions 
aimed at improving disease response, adaptation to the disease, 
and the ability to learn to live with chronic disease states.4 
Nurse scientists have published a great number of studies on 
the adaptation of patients following SCD, ICD implantation, 
and ICD shock therapy.4 It is equally important to note that 
the vast majority of the behavioral and psychosocial interven-
tions that intended to enhance QoL post ICD implantation 
were developed and tested by nurse scientists.4
nursing interventions. Nursing interventions, aimed at 
decreasing the psychological stress of living with heart dis-
ease, have identified reductions in anxiety and depression.20 
Medical conditions such as severe depression and anxiety dis-
order can be diagnosed and treated.6 Despite the acceptance of 
feelings as a significant part of the human condition, scientific 
knowledge of the effect of the clients’ emotions on their ability 
to cope is limited.21 Cardiac disease, including complications, 
will inevitably lead to a fundamental emotional reaction.6 
A defense mechanism is typically the primary emotional 
reaction linked to a healthy survival strategy.6 Although the 
reaction demonstrates the patient’s desire to develop healthy 
coping strategies,21 it is clear that emotion affects the ways in 
which the patient copes with illness.
education. Despite the advantage of ICD technology in 
survival rates, patients with an ICD experience a major disruption 
in their lives.22 Guidelines for nursing care have been published, 
highlighting that education is essential for ICD recipients.23 
The guidelines focus on the patient’s understanding of his or her 
condition, functions of the ICD, implantation procedure, preop-
erative and postoperative care, restrictions on activities of daily 
living, and discharge instructions.22 The underlying supposition 
is that the patient will process and understand the information 
received as well as adapt to daily life activities.24
review of literature
An extensive literature search using Center for health evidence 
(CCHNE.net), CINAHL, ClinicalTrials.gov, Cochrane, 
Embase, Guidelines.gov, Medline, PubMed, and OVID was 
undertaken to search for publications describing PTSD in 
ICD recipients. Each database was searched for the most cur-
rent evidence-based data, randomized controlled trial (RCT), 
systematic reviews including Evidence-based Practice Center, 
and Health Technology Assessment reviews and meta-analyses 
conducted between the years 2000 and 2015. Cohort or other 
prospective non-RCT designs were also considered. A total of 
26 guidelines and systematic reviews arrived at diverse con-
clusions, provided different recommendations, and observed 
different effectiveness of therapies,25 regarding PTSD in ICD 
patients. However, many guidelines identified trauma-focused 
psychological treatments as a preferred method viewing medi-
cations as an adjunct or a next-line treatment.25 The range of 
participant inclusion criteria included the assessment of one of 
the following outcomes: PTSD symptoms, remission (no lon-
ger having symptoms), QoL, disability or functional impair-
ment, or adverse events. Settings included outpatient and 
inpatient care, cardiovascular, electrophysiology (EP) clinic, 
primary care, and mental health care settings.
Ladwig et al.26 found that experiencing SCD outside of 
the hospital setting resulted in an even greater prevalence of 
Screening program for patients at risk for PTSD
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PTSD (27%–38%) among ICD recipients. A total of 48.6% 
of the sample had clinically significant levels of PTSD at 
any one point in time.26 ICD recipients with positive PTSD 
scores after device implantation were considerably more likely 
to have shock storm.27 These rates dropped significantly in the 
first six months after ICD implantation to 15% and remained 
stable at one year.27 von Känel et al.28 found a 31% preva-
lence of PTSD in ICD patients two years post implantation. 
At five and a half years post ICD implant, the PTSD preva-
lence had increased to 36%.28 A total of 19% of the participants 
had PTSD at both assessments, 12% had PTSD at baseline, 
and 18% had PTSD at the follow-up visit.28 Likewise, ele-
vated PTSD scores were associated with a 3.2 times greater 
likelihood of mortality within five years compared with ICD 
patients, with no to moderate symptom levels of PTSD, even 
after controlling for disease and demographic parameters.26 
Moreover, Ladwig et al.26 reported that the relative mortality 
risk was 3.45 (adjusted for age, gender, diabetes, left ventricu-
lar ejection fraction, beta-blocker use, depression, and anxiety) 
in ICD recipients with PTSD (high Impacts of events scale-
revised (IES-R) score) compared with those without PTSD.
Ladwig et al.26 found that prior ICD shocks had no 
influence on the experience of PTSD symptoms. In addition, 
Kapa et al.27 found that ICD recipients with shocks and those 
without shocks differed only in their scores on physical com-
ponent of the short form-36 health survey (SF36). Therefore, 
regardless of the occurrence of ICD shock, the experience of 
cardiac arrest, or being told of the potential threat, there is no 
evidence highlighting the incidence of PTSD in the first year 
after implantation.27
Methods
PTSD in ICD recipients is known to be associated with 
55% cardiac-specific mortality.29 It is important to recog-
nize PTSD symptoms early in this patient group due to the 
high risk of mortality and morbidity and equally important to 
ensure that they receive appropriate care to reduce their risk of 
detrimental outcomes. Clinical observations and an exhaustive 
literature review suggest that PTSD is frequently undetected 
in ICD recipients followed up at EP outpatient clinics. There 
were no known studies at the time of this project that screened 
ICD recipients all-inclusively, regardless of indication for the 
ICD implant on behalf of PTSD symptoms utilizing the PC: 
PTSD screen in the outpatient EP clinic. The focus of the 
project was to develop and implement a PTSD protocol using 
the PC: PTSD tool.
In our project, similar to the Ladwig et al.26 study, age and 
gender were evaluated. However, the baseline cardiovascular 
disease state and indication for ICD implant were excluded 
intentionally. The current project focused on screening all ICD 
recipients, regardless of ICD indication with the PC: PTSD 
tool for symptoms of PTSD in the outpatient EP clinic. The 
focus of the Ladwig et al.26 study was to evaluate for PTSD 
symptoms at baseline and predict long-term mortality risk 
in patients with ICDs. Although the focus of the study was 
different, both studies were performed in a similar urban and 
suburban outpatient clinic and all participants were screened 
for PTSD symptoms. Our project evaluated the PTSD preva-
lence and was compared accordingly in which prevalence was 
determined as the proportion of patients with positive symp-
toms of PTSD. Based on the previous research by Ladwig 
et al.26, implementing the PC: PTSD screening tool to ICD 
recipients in an EP outpatient clinic would demonstrate a 
greater than 20% prevalence of PTSD.
Following the institutional review board’s approval from 
the University of Alabama in Huntsville, Alabama, Washington 
University School of Medicine (WASHU) in St. Louis, 
Missouri, who approved a partial waiver of HIPAA autho-
rization, the patients were screened for PTSD using the 
validated PC: PTSD tool (Appendix A). Patients older 
than 19 years of age, with an ICD, were eligible for inclu-
sion in the project. The exclusion criteria included combative 
or confused patients without family support. The patients were 
asked to review the consent letter (Appendix B) and com-
plete the attached PC: PTSD screening tool (Appendix A). 
ICD patients, who agreed to participate, were screened dur-
ing their follow-up visits. All of the participants were identi-
fied through the electronic medical record (AllScripts) and 
recruited at WASHU in the EP clinic during their Usual 
customary care (UCC) visit. The research was conducted in 
accordance with the Declaration of Helsinki.
Implementation
Phase I of the project began with a presentation detailing the 
project goals, interventions, and expected outcomes to senior 
leadership, nursing management, and multidisciplinary office 
staff. A consent letter with the attached PC: PTSD screening 
tool was reviewed in detail (Appendices A–B). The PC: PTSD 
screening tool was developed by Annabel Prins et al.30 (2003) 
and was designed for use in primary care or other medical 
settings to screen for PTSD. It is a four- question tool that 
includes an introductory sentence, prompting respondents 
regarding traumatic events. Prins et al.30 (2003) suggested 
that any PC: PTSD screen should be considered positive for 
most participants with three “yes” responses to any item in 
the screen. 
Phase II of the project began with the completion of the 
administration and provider and staff training. Patients were 
identified using Allscripts, Washington University’s electronic 
medication record. All patients with an ICD aged 19 years and 
older were given the informed consent letter with the attached 
PC: PTSD survey. By the end of 12 days, 50 participants had 
completed the attached survey. Nine of the 50 participants 
had positive findings on the screening. Each patient with a 
positive PC: PTSD survey was referred to a mental health 
specialist for further evaluation and treatment. We expected 
a 20% prevalence rate of PTSD in the EP outpatient clinic of 
the participating patients.
Roberts et al
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Phase III of the project began when enrollment of 
50 participants was met. SAS v9.4 software was used to cal-
culate the prevalence of PTSD in ICD recipients in the EP 
outpatient clinic, and all data were compared to the work by 
Ladwig et al.26, demonstrating a greater than 20% burden. 
The project coordinator tracked this information.
Framework
The biopsychosocial model (BPS), used as the framework for 
this project, assisted medical personnel in facilitating and/or 
promoting healthy client behaviors.31 BPS entails the concep-
tualization and treatment of health problems as an interplay 
between biological factors, psychological factors, and social fac-
tors, culminating in the manifestation of symptoms.32 The BPS 
is predicted to be the best theoretical framework capable of 
establishing a therapeutic process or producing an antithera-
peutic effect on ICD patients suffering from PTSD.33 Screen-
ing to identify ICD recipients who are currently suffering or are 
at risk of PTSD signifies the need for comprehensive, superior 
care, consistent with BPS.31 The BPS allows healthcare pro-
fessionals to expand their analyses, diagnoses, and treatment 
of illness.34
Evidenced-based interventions with proven patient 
outcomes are essential in clinical practice.4 Nursing leader-
ship requires promoting change and expanding the nurses’ 
scope of practice. This requires the nurses to demonstrate 
leadership and educational reform in their practice.4 The 
Institute of Medicine Report on “The Future of Nursing: 
Leading Change Advancing Health” endorsed the need 
for nurses to coordinate care among clinician and health-
care agencies, prevent occurrences of acute care episodes, 
and be involved in managing chronic illness and disease 
progression, resulting in prevention of rehospitaliza-
tion.35 Nurses are in an optimal position to affect impor-
tant disease outcomes for patients and their families after 
ICD implantation.4
evaluation
In this project, a structured PTSD screening protocol using 
the PC: PTSD tool was administered to all ICD patients in 
a large EP outpatient clinic in the Midwestern United States. 
A 30-day time frame was utilized to obtain consent and screen 
participants. The data were extracted from the electronic 
health record used in the facility.
Project costs. The costs of materials and staffing time 
were eliminated, as the health administrators determined that 
the evaluations of PTSD in post ICD implants met the cur-
rent standard of care. There were no salary costs associated 
with the project.
results
The purpose of this analysis was to determine the prevalence 
of PTSD among patients with ICD implants seen during 
outpatient EP clinic visits and to establish a referral protocol 
to mental health services for any positive PC: PTSD screen. 
A positive response to the PC: PTSD screen was defined 
by three “yes” responses to any of the four screen questions. 
The proportion of patients having PTSD and an exact 95% 
confidence interval based on the binomial distribution are 
presented in Table 1. Comparisons between PTSD and 
non-PTSD patients were done using a two-sample t-test 
for continuous variables and Fisher’s exact test for categori-
cal statistics (Table 2). PTSD prevalence was compared to 
Ladwig et al.26 study prevalence using Fisher’s exact test 
(Fig. 1). In the Ladwig et al.26 study, prevalence was deter-
mined as the proportion of patients having a positive PTSD 
result (n = 38 of 147). All analyses were conducted using 
SAS v9.4.
A total of 50 ICD recipients (33 male and 17 female) 
participated in the project. A total of 18% of the partici-
pants had a positive PC: PTSD screen. Each participant 
with a positive PC: PTSD screen, nine patients in total, 
was referred to mental health specialists for further evalu-
ation and treatment. When evaluating the PTSD symp-
toms from the time of the ICD implant (2009–2015), an 
increased burden of PTSD symptoms was observed in the 
group of participants with ICD implanted in 2015 (26%), 
compared to those with ICD implanted in 2009 (6%; Fig. 2). 
The evaluation of the responses to the PC: PTSD question 
demonstrated significant findings (Fig. 3). A total of 26% of 
the overall patient group experienced nightmares during the 
previous 30 days (P = 0.001). Within the same patient group, 
31% reported symptoms of avoidance (P = 0.001). A total 
of 20% of these patients reported that they felt on guard 
(P = 0.001) and 24% of this group documented that they felt 
numb (P = 0.001). Ladwig et al.26 study reported a notable 
26% incidence rate compared to an 18% prevalence in the 
current sample (P = 0.34). This project did not demonstrate 
a 20% prevalence of PTSD symptoms as initially hypoth-
esized. However, the project did demonstrate a significant 
18% burden of PTSD.
discussion
Growing evidence suggests that PTSD symptomatology is 
highly prevalent in EP clinic and harmful to psychosocial and 
physical health. The current project supports the need for rou-
tine screening for the presence of PTSD in the outpatient EP 
clinic based upon the evidence found in the literature review 
and project findings. Utilization of the PC: PTSD screen as 
table 1. Prevalence of Ptsd in the outpatient eP clinic.
fREquEnCY/
total = PERCEnt
95% CI
Positive PC:Ptsd 
screen = yes
9/50 = 18% (8.6%, 31.4%)
note: The proportion of patients having PTSD and an exact 95% confidence 
interval based on the binomial distribution.
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table 2. Summary of statistical findings.
ovERall PC:PtSD vaRIablE (n = 50)
PC:PtSD
SCREEn = no
PtSD
SCREEn = YES
PtSD
P-valuE
age 62.28 + 15.68 64.93 + 13.10 50.22 + 21.98 0.08
gender no. (%) 1.00
F 17 (34%) 14 (34%) 3 (33%)
M 33 (66%) 27 (66%) 6 (67%)
ICD Implant Year, no. (%) 0.30
2009 3 (6%) 3 (7%) 0 (0%)
2010 6 (12%) 4 (10%) 2 (22%)
2011 3 (6%) 2 (5%) 1 (11%)
2012 7 (14%) 4 (10%) 3 (33%)
2013 13 (26%) 12 (29%) 1 (11%)
2014 5 (10%) 5 (12%) 0 (0%)
2015 13 (26%) 11 (27%) 2 (22%)
q1 had nightmares, no. (%) ,0.001
no 37 (74%) 37 (90%) 0 (0%)
yes 13 (26%) 4 (10%) 9 (100%)
q2 avoidance, no. (%) ,0.001
no 34 (69%) 34 (85%) 0 (0%)
yes 15 (31%) 6 (15%) 9 (100%)
q2 on guard, no. (%) ,0.001
no 40 (80%) 40 (98%) 0 (0%)
yes 10 (20%) 1 (2%) 9 (100%)
q2 felt numb, no. (%) ,0.001
no 37 (76%) 36 (90%) 1 (11%)
yes 12 (24%) 4 (10%) 8 (89%)
Referral made (Positive PC: PtSD Screen), no. (%) ,0.001
no 41 (82%) 41 (100%) 0 (0%)
yes 9 (18%) 0 (0%) 9 (100%)
note: Comparisons between Ptsd and non-Ptsd patients were done using a two-sample t-test for continuous variables and Fisher’s exact test for categorical 
statistics.
recipient’s implantable cardiac defibrillator, these results may 
not generalize to other populations. Second, though the PC: 
PTSD tool is a validated measure of PTSD, it has never been 
studied looking at the operating characteristics in the EP out-
patient clinic to screen for PTSD symptoms.
summary
There is an urgent need for a multidisciplinary approach to 
care for ICD recipients with PTSD symptoms as was dem-
onstrated by the current project. The increased prevalence 
of PTSD in ICD patients measured by this study as 18% 
supports the need and is consistent with previous research. 
PTSD symptoms are a key source of emotional distress in 
patients with ICDs. These symptoms may persist for years; 
therefore, they should not be overlooked. EP clinicians 
should screen regularly for PTSD symptoms, and those with 
a standard of care in an EP clinic on all ICD recipients would 
help identify patients at increased risk for PTSD. Early 
recognition and referral to a mental health specialist provides 
comprehensive, superior care. Given the known association of 
increased morbidity and mortality in patients with cardiovas-
cular disease and PTSD, this recommended practice standard 
becomes imperative for improved patient outcomes such as 
reducing the likelihood of future ICD shocks and increased 
mortality risk.
limitations
The findings from this study should be interpreted in light 
of several limitations. First, the study sample was relatively 
small and located in a large EP outpatient clinic in an urban 
community. While this is an important group to study, 
given their underlying all-inclusive cardiac indicators for the 
Roberts et al
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